U.S. market Closed. Opens in 11 hours 17 minutes

SHPH | Shuttle Pharmaceuticals Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312018-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue6.81K66.83K60.83K54.95K18.00K
Gross Profit-6.81K-66.83K-60.83K-54.95K-18.00K
Operating Expenses5.89M2.55M1.74M509.52K568.63K
Selling, General & Admin2.37M1.07M721.18K347.75K513.06K
Research & Development3.52M1.49M1.02M161.77K55.57K
Other Operating Expenses1.33M328.69KN/AN/AN/A
Operating Income-5.89M-2.55M-1.74M-509.52K-586.63K
Other Expenses / Income-700.34K-474.17K590.86K-296.21K-39.51K
Before Tax Income-6.59M-3.03M-1.15M-805.73K-626.14K
Income Tax Expenses-1.0071.01K50.79K39.63KN/A
Net Income-6.59M-3.10M-1.20M-845.36K-626.14K
Interest Expenses2.60M969.89K50.79K39.63K30.92K
Basic Shares Outstanding1.87M10.35M13.59M13.59M13.59M
Diluted Shares Outstanding1.87M10.35M13.59M13.59M13.59M
EBITDA-5.89M-2.16M-1.68M-454.57K-568.63K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-4.00M-2.06M-1.10M-766.10K-595.22K
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙